CEG: Full Drug Profile
CEG - General Information
A cephalorsporin antibiotic.
Pharmacology of CEG
CEG is an antibiotic related to cephalosporin but no longer in common use. It is an orally absorbed derivative of cephalosporin C.
Additional information about CEG
CEG Indication: For treatment of severe infections caused by susceptible bacteria. Mechanism Of Action: The bactericidal activity of cephaloglycin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Cephaloglycin Synonyms: Not Available Drug Category: Anti-Bacterial Agents Drug Type: Small Molecule; Approved Other Brand Names containing Cephaloglycin: CEG; Cefaloglicina [INN-Spanish]; Cefaloglycin; Cefaloglycine [INN-French]; Cefaloglycinum [INN-Latin]; Cephaloglycin anhydrous; Cephaloglycine; Cephaoglycin acid; D-Cephaloglycine; Kafocin; Kefglycin; Absorption: Well absorbed following oral administration. Toxicity (Overdose): Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions. Protein Binding: Not Available Biotransformation: Not Available Half Life: Not Available Dosage Forms of CEG: Not Available Chemical IUPAC Name: (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical Formula: C18H19N3O6S Cephaloglycin on Wikipedia: https://en.wikipedia.org/wiki/Cephaloglycin Organisms Affected: Enteric bacteria and other eubacteria
